ARB therapeutic interchange evaluation in patients with hypertension
碩士 === 臺北醫學大學 === 藥學系 === 93 === Objective: To evaluate clinical outcomes of subjects whose therapy was converted from other ARBs to candesartan, determine the efficacy and safety of candesartan in patients with hypertension, and patients’ satisfaction. Efficacy analysis was the changes in blood pre...
Main Authors: | Tzu-yun Huang, 黃子芸 |
---|---|
Other Authors: | Yi Ho |
Format: | Others |
Language: | zh-TW |
Published: |
2005
|
Online Access: | http://ndltd.ncl.edu.tw/handle/08608260812037717817 |
Similar Items
-
Therapeutic Interchange Evaluation of HMG-CoA Reductase Inhibitors in Patients with Dyslipidemia
by: Lin, Hong-Yun, et al.
Published: (2006) -
Possibilities ARB II (sartans) in hypertensive patients
by: T E Morozova, et al.
Published: (2014-09-01) -
Efficacy of ARB/HCTZ Combination Therapy in Uncontrolled Hypertensive Patients Compared with ARB Monotherapy: A Meta-Analysis
by: Linlin Ma, et al.
Published: (2021-01-01) -
ARB Compared with non-ARB in Preventing Cardiac Events in High Risk Hypertensive Patients: An Evidence Based Case Report
by: Alvin Nursalim, et al.
Published: (2013-06-01) -
Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension
by: Jing Ma, et al.
Published: (2021-05-01)